Table 2. Differentially Expressed Proteins in Hyperuricemia Compared to Normal Control^a.

symbol	accession	description	p value	fold change	change
ITIH3	Q06033	inter-α-trypsin inhibitor heavy chain H3	0.0015	0.5404	downregulation
CFAD	P00746	complement factor D	0.0292	0.5322	downregulation
APOC3	P02656	apolipoprotein C-III	0.0140	0.5883	downregulation
VATB1	P15313	V-type proton ATPase subunit B kidney isoform	0.0052	0.5990	downregulation
CYTM	Q15828	cystatin-M	0.0112	0.4469	downregulation
FACE1	O75844	CAAX prenyl protease 1 homolog	0.0351	0.6010	downregulation
VPP4	Q9HBG4	V-type proton ATPase 116 kDa subunit a isoform 4	0.0076	0.6057	downregulation
RNF13	O43567	E3 ubiquitin-protein ligase RNF13	0.0091	0.6572	downregulation
APOA4	P06727	apolipoprotein A-IV	0.0383	0.6431	downregulation
ITLN1	Q8WWA0	intelectin-1	0.0422	0.0624	downregulation
PDGFRB	P09619	platelet-derived growth factor receptor β	0.0462	0.5782	downregulation
HBM	Q6B0K9	hemoglobin subunit mu	0.0311	8.5500	upregulation
CNTFR	P26992	ciliary neurotrophic factor receptor subunit α	0.0419	1.7430	upregulation

^aFold change, the fold change (HUA/control).